Adapting brain metabolism to myelination and long-range signal transduction

GLIA

Volumn 62, Issue 11, 2014, Pages 1749-1761

  Hirrlinger, Johannes ^a,b,c   Nave, Klaus Armin ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Carl Ludwig Institute of Physiology   (Germany)

Author keywords

Astrocytes; Axon; Cholesterol; Energy metabolism; Myelin; Oligodendrocyte

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOGEN; LACTIC ACID; LIPID; MEMBRANE PROTEIN; MYELIN; N ACETYLASPARTIC ACID; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADAPTATION; ASTROCYTE; BRAIN METABOLISM; CELL FUNCTION; CELL METABOLISM; ENERGY METABOLISM; FATTY ACID SYNTHESIS; FEEDBACK SYSTEM; GLIA CELL; HUMAN; METABOLITE; MYELIN SHEATH; MYELINATION; NERVE FIBER; NERVE FIBER TRANSPORT; OLIGODENDROGLIA; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; WHITE MATTER; ANIMAL; BRAIN; METABOLISM; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN; ENERGY METABOLISM; HUMANS; MYELIN SHEATH; SIGNAL TRANSDUCTION;

EID: 84912561714     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22737     Document Type: Review

References (156)

1. Amaral AI, Meisingset TW, Kotter MR, Sonnewald U. 2013. Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front Endocrinol (Lausanne) 4:54.
2. Antonicka H, Leary SC, Guercin GH, Agar JN, Horvath R, Kennaway NG, Harding CO, Jaksch M, Shoubridge EA. 2003. Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, earlyonset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 12:2693-2702.
3. Ariyannur PS, Madhavarao CN, Namboodiri AM. 2008. N-acetylaspartate synthesis in the brain: mitochondria vs. microsomes. Brain Res 1227:34-41.
4. Ariyannur PS, Moffett JR, Manickam P, Pattabiraman N, Arun P, Nitta A, Nabeshima T, Madhavarao CN, Namboodiri AM. 2010. Methamphetamineinduced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Res 1335:1-13.
5. Balice-Gordon RJ, Bone LJ, Scherer SS. 1998. Functional gap junctions in the schwann cell myelin sheath. J Cell Biol 142:1095-1104.
6. Banki K, Colombo E, Sia F, Halladay D, Mattson DH, Tatum AH, Massa PT, Phillips PE, Perl A. 1994. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med 180:1649-1663.
7. Barros LF. 2013. Metabolic signaling by lactate in the brain. Trends Neurosci 36:396-404.
8. Berger T, Walz W, Schnitzer J, Kettenmann H. 1992. GABA- and glutamateactivated currents in glial cells of the mouse corpus callosum slice. J Neurosci Res 31:21-27.
9. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C, Coyle JT. 1999. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol 415:52-64.
10. Bergersen LH, Gjedde A. 2012. Is lactate a volume transmitter of metabolic states of the brain? Front Neuroenergetics 4:5.
11. Bittner CX, Valdebenito R, Ruminot I, Loaiza A, Larenas V, Sotelo-Hitschfeld T, Moldenhauer H, San MA, Gutierrez R, Zambrano M, Barros LF. 2011. Fast and reversible stimulation of astrocytic glycolysis by K1 and a delayed and persistent effect of glutamate. J Neurosci 31:4709-4713.
12. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. 2002. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51:51- 58.
13. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. 2000. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893-901.
14. Bjorkhem I, Meaney S. 2004. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24:806-815.
15. Black JA, Waxman SG. 1998. The perinodal astrocyte. Glia 1:169-183.
16. Boretius S, Tammer R, Michaelis T, Brockmoller J, Frahm J. 2013. Halogenated volatile anesthetics alter brain metabolism as revealed by proton magnetic resonance spectroscopy of mice in vivo. Neuroimage 69:244-255.
17. Brady ST, Lasek RJ. 1981. Nerve-specific enolase and creatine phosphokinase in axonal transport: soluble proteins and the axoplasmic matrix. Cell 23:515-523.
18. Brown AM, Ransom BR. 2007. Astrocyte glycogen and brain energy metabolism. Glia 55:1263-1271.
19. Brown AM, Tekkok SB, Ransom BR. 2003. Glycogen regulation and functional role in mouse white matter. J Physiol 549:501-512.
20. Bruzzone R, White TW, Paul DL. 1996. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238:1-27.
21. Burri R, Steffen C, Herschkowitz N. 1991. N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev Neurosci 13:403-411.
22. Burt AM. 1971. Activity of glutamate and malate dehydrogenases and the 'malic enzyme' during the development of the chick spinal cord. Int J Neurosci 2:283-291.
23. Butt AM, Colquhoun K, Tutton M, Berry M. 1994a. Three-dimensional morphology of astrocytes and oligodendrocytes in the intact mouse optic nerve. J Neurocytol 23:469-485.
24. Butt AM, Duncan A, Berry M. 1994b. Astrocyte associations with nodes of Ranvier: ultrastructural analysis of HRP-filled astrocytes in the mouse optic nerve. J Neurocytol 23:486-499.
25. Butt AM, Ransom BR. 1989. Visualization of oligodendrocytes and astrocytes in the intact rat optic nerve by intracellular injection of lucifer yellow and horseradish peroxidase. Glia 2:470-475.
26. Cader S, Johansen-Berg H, Wylezinska M, Palace J, Behrens TE, Smith S, Matthews PM. 2007. Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage 36:19-27.
27. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264-278.
28. Cai TQ, Ren N, Jin L, Cheng K, Kash S, Chen R, Wright SD, Taggart AK, Waters MG. 2008. Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochem Biophys Res Commun 377:987-991.
29. Calingasan NY, Sheu KF, Baker H, Jung EH, Paoletti F, Gibson GE. 1995. Heterogeneous expression of transketolase in rat brain. J Neurochem 64: 1034-1044.
30. Cambron M, D'Haeseleer M, Laureys G, Clinckers R, Debruyne J, De KJ. 2012. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab 32:413-424.
31. Cammer W, Snyder DS, Zimmerman TR Jr, Farooq M, Norton WT. 1982. Glycerol phosphate dehydrogenase, glucose-6-phosphate dehydrogenase, and lactate dehydrogenase: activities in oligodendrocytes, neurons, astrocytes, and myelin isolated from developing rat brains. J Neurochem 38:360- 367.
32. Choeiri C, Staines W, Messier C. 2002. Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience 111: 19-34.
33. Choi HB, Gordon GR, Zhou N, Tai C, Rungta RL, Martinez J, Milner TA, Ryu JK, McLarnon JG, Tresguerres M, Levin LR, Buck J, MacVicar BA. 2012. Metabolic communication between astrocytes and neurons via bicarbonateresponsive soluble adenylyl cyclase. Neuron 75:1094-1104.
34. Cotrina ML, Nedergaard M. 2012. Brain connexins in demyelinating diseases: therapeutic potential of glial targets. Brain Res 1487:61-68.
35. Czopka T, ffrench-Constant C, Lyons DA. 2013. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo. Dev Cell 25:599-609.
36. Daneman R. 2012. The blood-brain barrier in health and disease. Ann Neurol 72:648-672.
37. David G, Barrett JN, Barrett EF. 1992. Evidence that action potentials activate an internodal potassium conductance in lizard myelinated axons. J Physiol 445:277-301.
38. David G, Barrett JN, Barrett EF. 1993. Activation of internodal potassium conductance in rat myelinated axons. J Physiol 472:177-202.
39. de Monasterio-Schrader P, Jahn O, Tenzer S, Wichert SP, Patzig J, Werner HB. 2012. Systematic approaches to central nervous system myelin. Cell Mol Life Sci 69:2879-2894.
40. De Stefano N, Matthews PM, Arnold DL. 1995. Reversible decreases in Nacetylaspartate after acute brain injury. Magn Reson Med 34:721-727.
41. de Vries MG, Arseneau LM, Lawson ME, Beverly JL. 2003. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia. Diabetes 52:2767-2773.
42. Dienel GA, Ball KK, Cruz NF. 2007. A glycogen phosphorylase inhibitor selectively enhances local rates of glucose utilization in brain during sensory stimulation of conscious rats: implications for glycogen turnover. J Neurochem 102:466-478.
43. Dienel GA, Wang RY, Cruz NF. 2002. Generalized sensory stimulation of conscious rats increases labeling of oxidative pathways of glucose metabolism when the brain glucose-oxygen uptake ratio rises. J Cereb Blood Flow Metab 22:1490-1502.
44. Dietschy JM. 2009. Central nervous system: Cholesterol turnover, brain development and neurodegeneration. Biol Chem 390:287-293.
45. Dringen R, Gebhardt R, Hamprecht B. 1993. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res 623:208-214.
46. Dringen R, Hoepken HH, Minich T, Ruedig C. 2007. Pentose phosphate pathway and NADPH metabolism. In: Dienel G, Gibson G, editors. Handbook of neurochemistry and molecular neurobiology, Vol. 5: Neural energy utilization. Heidelberg: Springer Verlag. pp 41-62.
47. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de VJ. 1987. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18: 551-561.
48. Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Mobius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA. 2012. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517-521.
49. Furukawa-Hibi Y, Nitta A, Fukumitsu H, Somiya H, Toriumi K, Furukawa S, Nabeshima T, Yamada K. 2012. Absence of SHATI/Nat8l reduces social interaction in mice. Neurosci Lett 526:79-84.
50. Gandhi GK, Cruz NF, Ball KK, Theus SA, Dienel GA. 2009. Selective astrocytic gap junctional trafficking of molecules involved in the glycolytic pathway: impact on cellular brain imaging. J Neurochem 110:857-869.
51. Giaume C, Koulakoff A, Roux L, Holcman D, Rouach N. 2010. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 11:87-99.
52. Gibbs ME, Anderson DG, Hertz L. 2006. Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia 54:214-222.
53. Goodenough DA, Paul DL. 2009. Gap junctions. Cold Spring Harb Perspect Biol 1:a002576.
54. Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA. 2008. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456:745-749.
55. Hagenfeldt L, Bollgren I, Venizelos N. 1987. N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy. J Inherit Metab Dis 10:135-141.
56. Halestrap AP, Wilson MC. 2012. The monocarboxylate transporter family--role and regulation. IUBMB Life 64:109-119.
57. Harris AL. 2007. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 94:120-143.
58. Harris JJ, Attwell D. 2012. The energetics of CNS white matter. J Neurosci 32:356-371.
59. Heinzer S, Kuhn G, Krucker T, Meyer E, Ulmann-Schuler A, Stampanoni M, Gassmann M, Marti HH, Muller R, Vogel J. 2008. Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain. Neuroimage 39:1549-1558.
60. Henriksen O. 1995. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 8:139-148.
61. Hirrlinger J, Dringen R. 2010. The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63:177-188.
62. Hirrlinger J, Resch A, Gutterer JM, Dringen R. 2002. Oligodendroglial cells in culture effectively dispose of exogenous hydrogen peroxide: comparison with cultured neurones, astroglial and microglial cells. J Neurochem 82:635-644.
63. Hof PR, Pascale E, Magistretti PJ. 1988. K1 at concentrations reached in the extracellular space during neuronal activity promotes a Ca21-dependent glycogen hydrolysis in mouse cerebral cortex. J Neurosci 8:1922-1928.
64. Jung H, Yoon BC, Holt CE. 2012. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat Rev Neurosci 13:308-324.
65. Kamasawa N, Sik A, Morita M, Yasumura T, Davidson KG, Nagy JI, Rash JE. 2005. Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 136:65-86.
66. Karadottir R, Cavelier P, Bergersen LH, Attwell D. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162- 1166.
67. Klugmann M, Symes CW, Klaussner BK, Leichtlein CB, Serikawa T, Young D, During MJ. 2003. Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport 14:1837-1840.
68. Kofuji P, Newman EA. 2004. Potassium buffering in the central nervous system. Neuroscience 129:1045-1056.
69. Kolodziejczyk K, Hamilton NB, Wade A, Karadottir R, Attwell D. 2009. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain 132:1496-1508.
70. Kolodziejczyk K, Saab AS, Nave KA, Attwell D. 2010. Why do oligodendrocyte lineage cells express glutamate receptors? F1000 Biol Rep 2:57.
71. Kugler P. 1994. Glucose-6-phosphate dehydrogenase is enriched in oligodendrocytes of the rat spinal cord. Enzyme histochemical and immunocytochemical studies. Histochemistry 101:143-153.
72. Kukley M, Capetillo-Zarate E, Dietrich D. 2007. Vesicular glutamate release from axons in white matter. Nat Neurosci 10:311-320.
73. Kurz GM, Wiesinger H, Hamprecht B. 1993. Purification of cytosolic malic enzyme from bovine brain, generation of monoclonal antibodies, and immunocytochemical localization of the enzyme in glial cells of neural primary cultures. J Neurochem 60:1467-1474.
74. Lauritzen KH, Morland C, Puchades M, Holm-Hansen S, Hagelin EM, Lauritzen F, Attramadal H, Storm-Mathisen J, Gjedde A, Bergersen LH. 2013. Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism. Cereb Cortex. (Epub ahead of print).
75. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-448.
76. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, Sutton SW, Li X, Yun SJ, Mirzadegan T, Mazur C, Kamme F, Lovenberg TW. 2009. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J Biol Chem 284:2811-2822.
77. Losi G, Vicini S, Neale J. 2004. NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons. Neuropharmacology 46:490-496.
78. Lovato L, Cianti R, Gini B, Marconi S, Bianchi L, Armini A, Anghileri E, Locatelli F, Paoletti F, Franciotta D, Bini L, Bonetti B. 2008. Transketolase and 2',3'-cyclic-nucleotide 3'-phosphodiesterase type I isoforms are specifically recognized by IgG autoantibodies in multiple sclerosis patients. Mol Cell Proteomics 7:2337-2349.
79. Lu ZH, Chakraborty G, Ledeen RW, Yahya D, Wu G. 2004. N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Brain Res Mol Brain Res 122:71-78.
80. Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, Matalon R, Garbern J, Hristova D, Johnson A, Jiang W, Namboodiri MA. 2005. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci USA 102:5221-5226.
81. Madhavarao CN, Chinopoulos C, Chandrasekaran K, Namboodiri MA. 2003. Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem 86:824-835.
82. Magistretti PJ, Morrison JH, Shoemaker WJ, Sapin V, Bloom FE. 1981. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: A possible regulatory mechanism for the local control of energy metabolism. Proc Natl Acad Sci USA 78:6535-6539.
83. Magnotti LM, Goodenough DA, Paul DL. 2011. Deletion of oligodendrocyte Cx32 and astrocyte Cx43 causes white matter vacuolation, astrocyte loss and early mortality. Glia 59:1064-1074.
84. Maher F, Vannucci SJ, Simpson IA. 1994. Glucose transporter proteins in brain. FASEB J 8:1003-1011.
85. Matalon R, Rady PL, Platt KA, Skinner HB, Quast MJ, Campbell GA, Matalon K, Ceci JD, Tyring SK, Nehls M, Surendran S, Wei J, Ezell EL, Szucs S. 2002. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Genet Med 2:165-175.
86. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354-1357.
87. McNay EC, Gold PE. 1999. Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: Effects of microdialysis flow rate, strain, and age. J Neurochem 72:785-790.
88. Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E, Scherer SS, Paul DL. 2006. Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci 26:10984-10991.
89. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK. 2006. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439:988-992.
90. Mierzwa A, Shroff S, Rosenbluth J. 2010. Permeability of the paranodal junction of myelinated nerve fibers. J Neurosci 30:15962-15968.
91. Miller SL, Daikhin Y, Yudkoff M. 1996. Metabolism of N-acetyl-L-aspartate in rat brain. Neurochem Res 1996;21:615-618.
92. Minich T, Yokota S, Dringen R. 2003. Cytosolic and mitochondrial isoforms of NADP1-dependent isocitrate dehydrogenases are expressed in cultured rat neurons, astrocytes, oligodendrocytes and microglial cells. J Neurochem 86: 605-614.
93. Mochel F, Boildieu N, Barritault J, Sarret C, Eymard-Pierre E, Seguin F, Schiffmann R, Boespflug-Tanguy O. 2010. Elevated CSF Nacetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases. Biochim Biophys Acta 1802:1112- 1117.
94. Moffett JR, Arun P, Ariyannur PS, Garbern JY, Jacobowitz DM, Namboodiri AM. 2011. Extensive aspartoacylase expression in the rat central nervous system. Glia 59:1414-1434.
95. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. 2007. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89-131.
96. Moschen I, Broer A, Galic S, Lang F, Broer S. 2012. Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT). Neurochem Res 37:2562-2568.
97. Muse ED, Jurevics H, Toews AD, Matsushima GK, Morell P. 2001. Parameters related to lipid metabolism as markers of myelination in mouse brain. J Neurochem 76:77-86.
98. Nave KA. 2010a. Myelination and support of axonal integrity by glia. Nature 468:244-252.
99. Nave KA. 2010b. Myelination and the trophic support of long axons. Nat Rev Neurosci 11:275-283.
100. Neale JH, Olszewski RT, Zuo D, Janczura KJ, Profaci CP, Lavin KM, Madore JC, Bzdega T. 2011. Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family. J Neurochem 118:490-498.
101. Nelson SR, Schulz DW, Passonneau JV, Lowry OH. 1968. Control of glycogen levels in brain. J Neurochem 15:1271-1279.
102. Newman LA, Korol DL, Gold PE. 2011. Lactate produced by glycogenolysis in astrocytes regulates memory processing. PLoS One 6:e28427.
103. Nitkunan A, Charlton RA, McIntyre DJ, Barrick TR, Howe FA, Markus HS. 2008. Diffusion tensor imaging and MR spectroscopy in hypertension and presumed cerebral small vessel disease. Magn Reson Med 59:528-534.
104. Nordengen K, Heuser C, Rinholm JE, Matalon R, Gundersen V. 2013. Localisation of N-acetylaspartate in oligodendrocytes/myelin. Brain Struct Funct. (Epub ahead of print).
105. Nualart-Marti A, Solsona C, Fields RD. 2013. Gap junction communication in myelinating glia. Biochim Biophys Acta 1828:69-78.
106. O'Dowd BS, Gibbs ME, Ng KT, Hertz E, Hertz L. 1994. Astrocytic glycogenolysis energizes memory processes in neonate chicks. Brain Res Dev Brain Res 78:137-141.
107. Oblinger MM, Foe LG, Kwiatkowska D, Kemp RG. 1988. Phosphofructokinase in the rat nervous system: regional differences in activity and characteristics of axonal transport. J Neurosci Res 21:25-34.
108. Patel TB, Clark JB. 1979. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184:539-546.
109. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V. 1994. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12:357-371.
110. Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, Merle M, Costalat R, Magistretti PJ. 2007. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 55:1251-1262.
111. Pellerin L, Magistretti PJ. 1994. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625-10629.
112. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
113. Pfrieger FW. 2003. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays 25:72-78.
114. Pierre K, Pellerin L. 2005. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94:1-14.
115. Pierre K, Pellerin L, Debernardi R, Riederer BM, Magistretti PJ. 2000. Cellspecific localization of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double immunohistochemical labeling and confocal microscopy. Neuroscience 100:617-627.
116. Raine CS. 1984. On the association between perinodal astrocytic processes and the node of Ranvier in the C.N.S. J Neurocytol 13:21-27.
117. Ramos M, Pardo B, Llorente-Folch I, Saheki T, Del AA, Satrustegui J. Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain. J Neurosci Res 89:2008-2017.
118. Ransom BR, Fern R. 1997. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation? Glia 21:134-141.
119. Rash JE. 2010. Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience 168:982-1008.
120. Readhead C, Schneider A, Griffiths I, Nave KA. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
121. Requardt RP, Hirrlinger PG, Wilhelm F, Winkler U, Besser S, Hirrlinger J. 2012. Ca(2+) signals of astrocytes are modulated by the NAD(1) /NADH redox state. J Neurochem 20:1014-1025.
122. Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D. 2011. Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 31:538-548.
123. Rust Jr RS, Carter JG, Martin D, Nerbonne JM, Lampe PA, Pusateri ME, Lowry OH. 1991. Enzyme levels in cultured astrocytes, oligodendrocytes and Schwann cells, and neurons from the cerebral cortex and superior cervical ganglia of the rat. Neurochem Res 16:991-999.
124. Saab AS, Tzvetanova, ID, Nave KA. 2013. The role of myelin and oligodendrocytes in axonal energy metabolism. Curr Opin Neurobiol 23:1065-1072.
125. Sacha P, Zamecnik J, Barinka C, Hlouchova K, Vicha A, Mlcochova P, Hilgert I, Eckschlager T, Konvalinka J. 2007. Expression of glutamate carboxypeptidase II in human brain. Neuroscience 144:1361-1372.
126. Saez I, Duran J, Sinadinos C, Beltran A, Yanes O, Tevy MF, Martinez-Pons C, Milan M, Guinovart JJ. 2014. Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia. J Cereb Blood Flow Metab 34:945- 955.
127. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. 2005. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8:468-475.
128. Saher G, Quintes S, Nave KA. 2011. Cholesterol: A novel regulatory role in myelin formation. Neuroscientist 2011;17:79-93.
129. Saher G, Rudolphi F, Corthals K, Ruhwedel T, Schmidt KF, Lowel S, Dibaj P, Barrette B, Mobius W, Nave KA. 2012. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med 18:1130-1135.
130. Sanchez-Abarca LI, Tabernero A, Medina JM. 2001. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 36:321-329.
131. Sartori S, Burlina AB, Salviati L, Trevisson E, Toldo I, Laverda AM, Burlina AP. 2008. Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene. Eur J Paediatr Neurol 12:348-350.
132. Simons M, Kramer EM, Macchi P, Rathke-Hartlieb S, Trotter J, Nave KA, Schulz JB. 2002. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157:327-336.
133. Simons M, Trajkovic K. 2006. Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J Cell Sci 119:4381-4389.
134. Sotelo-Hitschfeld T, Fernandez-Moncada I, Barros LF. 2012. Acute feedback control of astrocytic glycolysis by lactate. Glia 60:674-680.
135. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, Alberini CM. 2011. Astrocyte-neuron lactate transport is required for longterm memory formation. Cell 144:810-823.
136. Suzuki M, Raisman G. 1992. The glial framework of central white matter tracts: segmented rows of contiguous interfascicular oligodendrocytes and solitary astrocytes give rise to a continuous meshwork of transverse and longitudinal processes in the adult rat fimbria. Glia 6:222-235.
137. Taylor DL, Davies SE, Obrenovitch TP, Doheny MH, Patsalos PN, Clark JB, Symon L. 1995. Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J Neurochem 65:275-281.
138. Tekkok SB, Brown AM, Westenbroek R, Pellerin L, Ransom BR. 2005. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J Neurosci Res 81: 644-652.
139. Theis M, Giaume C. 2012. Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res 1487:88-98.
140. Toyama BH, Savas JN, Park SK, Harris MS, Ingolia NT, Yates JR III, Hetzer MW. 2013. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154:971-982.
141. Tress O, Maglione M, May D, Pivneva T, Richter N, Seyfarth J, Binder S, Zlomuzica A, Seifert G, Theis M, Dere E, Kettenmann H, Willecke K. 2012. Panglial gap junctional communication is essential for maintenance of myelin in the CNS. J Neurosci 32:7499-7518.
142. Tress O, Maglione M, Zlomuzica A, May D, Dicke N, Degen J, Dere E, Kettenmann H, Hartmann D, Willecke K. 2011. Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans. PLoS Genet 7: e1002146.
143. Urazaev AK, Grossfeld RM, Fletcher PL, Speno H, Gafurov BS, Buttram JG, Lieberman EM. 2001. Synthesis and release of N-acetylaspartylglutamate (NAAG) by crayfish nerve fibers: implications for axon-glia signaling. Neuroscience 106:237-247.
144. van Heeswijk RB, Morgenthaler FD, Xin L, Gruetter R. 2010. Quantification of brain glycogen concentration and turnover through localized 13C NMR of both the C1 and C6 resonances. NMR Biomed 23:270-276.
145. Wallraff A, Kohling R, Heinemann U, Theis M, Willecke K, Steinhauser C. 2006. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J Neurosci 26:5438-5447.
146. Walls AB, Heimburger CM, Bouman SD, Schousboe A, Waagepetersen HS. 2009. Robust glycogen shunt activity in astrocytes: Effects of glutamatergic and adrenergic agents. Neuroscience 158:284-292.
147. Watanabe H, Passonneau JV. 1973. Factors affecting the turnover of cerebral glycogen and limit dextrin in vivo. J Neurochem 20:1543-1554.
148. Waxman SG, Ritchie JM. 1993. Molecular dissection of the myelinated axon. Ann Neurol 33:121-136.
149. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Mobius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave KA. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27:7717-7730.
150. Wiame E, Tyteca D, Pierrot N, Collard F, Amyere M, Noel G, Desmedt J, Nassogne MC, Vikkula M, Octave JN, Vincent MF, Courtoy PJ, Boltshauser E, van SE. 2010. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 425:127-136.
151. Wilhelm F, Hirrlinger J. 2012. Multifunctional roles of NAD(1) and NADH in astrocytes. Neurochem Res 37:2317-2325.
152. Wroblewska B, Wroblewski JT, Pshenichkin S, Surin A, Sullivan SE, Neale JH. 1997. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 1997;69:174-181.
153. Yuan A, Mills RG, Bamburg JR, Bray JJ. 1999. Cotransport of glyceraldehyde-3-phosphate dehydrogenase and actin in axons of chicken motoneurons. Cell Mol Neurobiol 19:733-744.
154. Zala D, Hinckelmann MV, Yu H, Lyra da Cunha MM, Liot G, Cordelieres FP, Marco S, Saudou F. 2013. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 152:479-491.
155. Ziabreva I, Campbell G, Rist J, Zambonin J, Rorbach J, Wydro MM, Lassmann H, Franklin RJ, Mahad D. 2010. Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes. Glia 58:1827-1837.
156. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE. 2007. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10:321-330.